Inicio › Cáncer de pulmón › Míchigan › Ann Arbor
Ensayos clínicos de Cáncer de pulmón en Ann Arbor, MI
22 estudios para Cáncer de pulmón buscan participantes en centros de Ann Arbor y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · A 15 mi de distancia
- y 2 más
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- y 4 más
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ReclutandoFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- y 4 más
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ReclutandoFase 3
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · A 15 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · A 18 mi de distancia
A Registry for People With Lung Cancer
ReclutandoEstudio observacional
- University of Michigan (Data Collection Only), Ann Arbor
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
ReclutandoFase 2/3
- Local Institution - 0418, Ann Arbor
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
ReclutandoFase 1/2
- University of Michigan Medical School Rogel Cancer Center, Ann Arbor
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- University of Michigan, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- y 4 más
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
ReclutandoFase 3
- University of Michigan, Ann Arbor
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ReclutandoFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Chelsea Hospital, Chelsea · A 15 mi de distancia
- y 3 más
Prediction Augmented Screening Initiative
Reclutando
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Gilteritinib for the Treatment of ALK NSCLC
ReclutandoFase 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- y 4 más
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- y 4 más
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · A 15 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · A 18 mi de distancia
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
ReclutandoFase 1/2
- University of Michigan, Ann Arbor
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Reclutando
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
ReclutandoFase 1/2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Reclutando
- University of Michigan Comprehensive Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Ann Arbor
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
ReclutandoFase 1/2
- University of Michigan, Ann Arbor
Más información sobre Cáncer de pulmón en MedlinePlus
Ensayos de Cáncer de pulmón en otras ciudades
- Houston, TX78 estudios
- Boston, MA62 estudios
- New York City, NY60 estudios
- Los Angeles, CA45 estudios
- Washington, DC41 estudios
- Chicago, IL41 estudios
- Baltimore, MD40 estudios
- Arlington, VA40 estudios
- Nashville, TN40 estudios
- St. Louis, MO39 estudios
- Columbus, OH36 estudios
- Philadelphia, PA36 estudios
Otros estudios en Ann Arbor
- Cáncer de próstata27 estudios
- Cáncer de seno26 estudios
- Cáncer (todos los tipos)26 estudios
- Cáncer de pulmón de células no pequeñas25 estudios
- Cáncer del colon y del recto23 estudios
- Fallo cardíaco22 estudios
- Leucemia mielógena aguda17 estudios
- Enfermedad cardiovascular16 estudios
- Cáncer de páncreas14 estudios
- Melanoma12 estudios
- Cáncer de riñón (carcinoma de células renales)12 estudios
- Fibrilación auricular11 estudios
De ClinicalTrials.gov, datos obtenidos el 29 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.